Scientific Advisory Board Member and Consultant at NeurAegis, Inc. - Southborough, MA, US
NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. Founded in 2016, our initial focus is developing first-in-class, novel protease inhibitors for traumatic brain injury where there are currently no FDA approved treatments.